Clinical Trials Logo

Filter by:
NCT ID: NCT00997906 Active, not recruiting - Clinical trials for Head and Neck Cancer

Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC

Start date: September 15, 2009
Phase: Phase 2/Phase 3
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as cisplatin, gemcitabine hydrochloride, carboplatin, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving chemotherapy together with radiation therapy my kill more tumor cells. It is not yet known whether giving cisplatin together with radiation therapy is more effective with or without gemcitabine hydrochloride, carboplatin, and paclitaxel in treating patients with nasopharyngeal cancer. PURPOSE: This randomized phase II/III trial is studying how well giving cisplatin together with radiation therapy works compared with giving cisplatin and radiation therapy together with gemcitabine hydrochloride, carboplatin, and paclitaxel in treating patients with locally advanced nasopharyngeal cancer.

NCT ID: NCT00995709 Completed - Behcet Disease Clinical Trials

Phase III Study in Refractory Behcet's Disease

SHIELD
Start date: October 2009
Phase: Phase 3
Study type: Interventional

The purpose of this pivotal trial is to evaluate subcutaneous (SQ) AIN457 as an adjunctive therapy to reduce the rate of exacerbations of posterior uveitis or panuveitis secondary to Behçet's disease during the 24 weeks of study therapy as compared to standard of care alone.

NCT ID: NCT00991016 Terminated - Healthy Volunteers Clinical Trials

Single and Multiple Dose Safety, Tolerability, and Pharmacokinetics Study of PF-04805712 in Healthy Volunteers

Start date: October 2009
Phase: Phase 1
Study type: Interventional

To assess the safety and tolerability of escalating single and multiple doses of the compound in healthy volunteers

NCT ID: NCT00990964 Completed - Heart Failure Clinical Trials

Attain Success Clinical Trial

Start date: November 2009
Phase: N/A
Study type: Observational

The purpose of the study is to assess lead implant success and complication rate using the Medtronic Attain Family of left-heart leads and delivery catheters.

NCT ID: NCT00990756 Completed - Healthy Clinical Trials

A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03526299 In Healthy Adult Volunteers

Start date: November 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate safety and toleration of multiple inhaled doses as well as the time course of PF-03526299 concentration in the blood following dosing by dry powder inhaler.

NCT ID: NCT00989989 Completed - Clinical trials for Diabetic Macular Edema

Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema

REVEAL
Start date: September 2009
Phase: Phase 3
Study type: Interventional

This study was designed to confirm the efficacy and safety of ranibizumab (0.5 mg) as adjunctive therapy when added to laser photocoagulation and/or as monotherapy in Asian patients with visual impairment due to Diabetic Macular Edema (DME).

NCT ID: NCT00989391 Completed - Healthy Clinical Trials

A Study In Healthy People To Investigate The Safety, Toleration And Time Course Of Blood Concentrations Of Multiple Doses Of PF-03654764, Given By Mouth

Start date: October 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study in heathy people is to investigate the safety, toleration and time course of PF-03654764 in the blood, following multiple doses given once or twice daily by mouth for 10 days.

NCT ID: NCT00988949 Completed - Bipolar Depression Clinical Trials

Proof Of Mechanism Study To Determine Efficacy Of PF-04455242 In Blocking Spiradoline (PF-00345768) Stimulated Prolactin Release

Start date: November 2009
Phase: Phase 1
Study type: Interventional

This study will be a Proof of Mechanism (POM) study to establish evidence of central pharmacodynamic activity for PF 04455242, and will be a parallel group, randomized, double blind, sponsor open study conducted in healthy male subjects. Once subjects achieve steady state of PF 04455242, they will undergo PF 00345768 (spiradoline) challenge. Data will be analyzed to determine whether PF-04455242 blocks spiradoline induced prolactin release.

NCT ID: NCT00988819 Recruiting - Healthy Clinical Trials

To Investigate the Influence of Ethnicity in Metabolic Disease in Healthy, Overweight and Obese Subjects

SAMS-1
Start date: July 2009
Phase: N/A
Study type: Observational

The overall objective of this study is to investigate in depth the nature of metabolic physiology, body composition and epigenetic differences of the different phenotypes of overweight and obese individuals who are otherwise overtly healthy among the three major ethnic groups in Singapore.

NCT ID: NCT00987779 Completed - Healthy Clinical Trials

Bioequivalence Study Of Gabapentin Between Tablet And Liquid Formulation And The Food Effect Study Of Liquid Formulation

Start date: October 2009
Phase: Phase 1
Study type: Interventional

Primary objective for this study is to demonstrate bioequivalence between Japanese commercial tablet and Japanese commercial image liquid formulation. Secondary objective for this study is to estimate the food effect for Japanese commercial image liquid formulation.